VSTM FY 2022 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$388M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+26.4% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$73M-2809.6% margin

Net Income

-$74M-2843.3% margin

EPS (Diluted)

$-4.57

Cash Flow

Operating Cash Flow

-$64M

Free Cash Flow

-$64M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$95M

Total Liabilities

$48M

Stockholders' Equity

$47M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+26.4%
Gross Profit	$3M	$2M	+26.4%
Operating Income	-$73M	-$61M	-18.8%
Net Income	-$74M	-$71M	-3.7%